Skip to main content
RESOURCE

Opioid Induced Hypogonadism: How Opioids, Methadone, and Buprenorphine Lower Testosterone — and What to Do Next

Affiliate disclosure: TRT Provider Guide may earn compensation through certain provider links. Commercial relationships do not change our editorial conclusions. Full disclosure.

Educational information, not medical advice. If you have severe symptoms — such as fainting, severe vomiting, or confusion — call 911 or go to the nearest emergency room.

Opioid induced hypogonadism is testosterone deficiency linked to opioid suppression of the hormone signals that support testosterone production. In pooled studies, 63% of mostly male long-term opioid users had hypogonadism, but that rate cannot diagnose an individual. Methadone and some long-acting opioids show stronger associations; buprenorphine generally shows less suppression.

So if you take opioids and you've lost your sex drive, your energy, or your edge, you're not imagining it. And you're far from alone.

But here's what most pages on opioid induced hypogonadism leave out. Three things decide whether you get real help or get stuck:

  • It needs proof, not a guess. A diagnosis takes symptoms or signs plus consistently low testosterone, confirmed with repeat morning testing. Tell the clinician when you last took your opioid because short-acting opioids can temporarily affect testosterone levels.
  • Never cut, skip, or switch your opioid on your own. Sudden changes can cause withdrawal, uncontrolled pain, or relapse. Your prescriber or treatment program makes that call with you.
  • Tired on opioids isn't always low testosterone. Opioids can also, rarely, cause a cortisol problem called adrenal insufficiency. Nausea, vomiting, dizziness, weakness, or low blood pressure need prompt medical care.

We'll walk through all three. First, find yourself in the table below.

TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.

Start here: your situation, your next step

Opioid-induced hypogonadism: testing, opioid evidence and treatment options table 1: Start here: your situation, your next step
Your situation Your best next step
Symptoms, but no testosterone test yet Start with a morning testosterone test; if it is low, confirm it and ask whether LH and FSH are needed to identify the cause
One low testosterone result Confirm it with a second morning test before assuming anything
Short course of opioids after surgery or injury Temporary opioid use can lower testosterone; ask about testing if symptoms persist or your clinician thinks a workup is needed
Daily opioids for chronic pain Get proper testing, then review the pain plan with your prescriber
Methadone for opioid use disorder Raise it with your treatment program — it's a known side effect, not a red flag about you
Buprenorphine (Suboxone, Sublocade) Get tested the same way — "milder" doesn't mean "never"
Trying to have a baby now or soon See a reproductive urologist before any testosterone
Nausea, vomiting, dizziness, weakness, or low blood pressure Get medical care promptly — ask about cortisol, not just testosterone

Which Opioids Are Most Strongly Linked to Low Testosterone?

Studies link methadone, transdermal fentanyl, oxycodone, and long-acting opioid exposure with higher odds of androgen deficiency than some comparison opioids, while buprenorphine generally shows milder gonadal-axis suppression than methadone. Dose can matter too. These are group-level findings, not a prediction for any one person.

We pulled the numbers from multiple studies and put them side by side. You won't find this exact comparison in one source. Here's what the research shows, opioid by opioid.

The opioid testosterone impact table

Opioid-induced hypogonadism: testing, opioid evidence and treatment options table 2: The opioid testosterone impact table
Opioid or situation What the study found Study size and type Source
Any long-term opioid (pooled) About 63% of men had hypogonadism 15 studies, 3,250 patients (meta-analysis) de Vries et al., JCEM, 2020
Regular opioid use vs. no opioids Testosterone averaged about 165 ng/dL lower in men who used opioids. Women showed no difference. 17 studies, 2,769 people (meta-analysis) Bawor et al., 2015
Long-acting vs. short-acting opioids (pain) Low testosterone in 74% on long-acting vs. 34% on short-acting — about 4.8× the odds after adjusting for dose and weight 81 men, pain clinic Rubinstein et al., Clinical Journal of Pain, 2013
Long-acting vs. short-acting (larger group) 57% vs. 35% — about 3.4× the odds 1,585 men Rubinstein & Carpenter, American Journal of Medicine, 2014
Fentanyl patch About 26× the odds of low testosterone vs. hydrocodone (a very wide range: 2.8× to 235×) 1,159 men Rubinstein & Carpenter, Pain Medicine
Methadone (for pain) About 7.3× the odds vs. hydrocodone 1,159 men Rubinstein & Carpenter, Pain Medicine
Oxycodone About 3.2× the odds vs. hydrocodone 1,159 men Rubinstein & Carpenter, Pain Medicine
Hydrocodone The comparison group. Odds rose about 18% for every extra 10 mg a day. 1,159 men Rubinstein & Carpenter, Pain Medicine
Methadone treatment for opioid use disorder 65% below about 346 ng/dL; 39% below about 231 ng/dL Men on methadone or buprenorphine Hallinan et al.
Buprenorphine treatment for opioid use disorder 28% below about 346 ng/dL; 11% below about 231 ng/dL Same study Hallinan et al.
Methadone vs. buprenorphine (second study) 40.8% of men on methadone vs. 22.6% on buprenorphine had testosterone below the lab's normal range 76 men on methadone, 31 on buprenorphine Yee et al., Journal of Sexual Medicine, 2018
Intrathecal (pump) opioids Testosterone dropped sharply within the first week and stayed low Small prospective study Reported in BMJ, 2010

1 nmol/L equals about 28.8 ng/dL. "Odds" tells you how often low testosterone showed up compared with the comparison group — not how low it went.

How to read this table without scaring yourself

  • Wide ranges mean small numbers. Fentanyl's range runs from about 3× to 235×. Treat that as a strong warning sign, not a precise number.
  • Your own story matters more. Your dose, how long you've taken it, your weight, your age, and your other health problems all change the picture.
  • We didn't rank opioids we couldn't back up. We didn't find strong enough human data on tramadol or kratom to put them in the table.

Why long-acting opioids may hit harder

The study authors offered a likely reason. A long-acting opioid keeps a steady level in your blood. That keeps the brain's "make testosterone" signal turned down around the clock. Short-acting doses rise and fall, so the signal may partly bounce back between doses. That's their proposed explanation, not settled science. It is a proposed explanation, not settled science.

Don't use a percentage as your diagnosis

A number like 63% tells you this is common. It doesn't tell you whether you have it. The question that matters is simple: do you have symptoms and consistently low testosterone on proper testing? And what's causing it? Your opioid is a strong suspect. It isn't automatically the only one.

The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use the care tables and appointment questions on this page with your clinician. Once the opioid-related evaluation and any specialist concerns have been addressed, TRT Provider Guide's Find My TRT Path tool can help you compare online TRT options.

Know your opioid, but not your next move? Use this page's testing checklist and appointment questions with your clinician or treatment program. After the evaluation is complete and your clinician agrees online TRT is an appropriate option to explore, Find My TRT Path can help you compare online programs. Explore online TRT options → Free. Educational, not a diagnosis.


What Is Opioid Induced Hypogonadism?

Opioid induced hypogonadism — also called opioid-induced androgen deficiency, or OPIAD — is hypogonadism associated with opioid suppression of the hypothalamic-pituitary-gonadal axis. In men it usually appears as secondary, or hypogonadotropic, hypogonadism: testosterone is low while the brain and pituitary signals that should stimulate the testicles are low or inappropriately normal.

Hypogonadism just means your body isn't making enough sex hormones. Doctors split it into two kinds:

  • Primary: the testicles themselves can't make enough testosterone.
  • Secondary: the problem is upstream in the hypothalamus or pituitary, so the testicles are not receiving the normal hormone signal.

Opioids usually cause the secondary kind. Think of a thermostat and a furnace. Your brain is the thermostat. Your testicles are the furnace. Opioids can turn the thermostat down, so the furnace gets a weaker signal.

That suppression can improve when opioid exposure is reduced or stopped, but recovery varies. A low testosterone result still needs a full evaluation because opioids may not be the only cause.

Is this an official, recognized side effect?

Yes. In 2016, the FDA required every opioid label to include information about lower sex-hormone levels. The FDA made clear this applies whether the opioid treats pain or treats opioid use disorder. The Endocrine Society's 2024 scientific statement on opioids calls hypogonadism a well-recognized opioid side effect.

So if you've felt brushed off, this is a recognized medical issue with FDA labeling and Endocrine Society guidance behind it.

Not to be confused with opioid-induced hyperalgesia

Both conditions sometimes get shortened to "OIH." Opioid-induced hyperalgesia is when opioids make you more sensitive to pain. This page is about hormones. For the basics of low testosterone in general, see What Is Hypogonadism?


Why Do Opioids Lower Testosterone?

Opioids act on the part of the brain (the hypothalamus) that releases GnRH, the hormone that starts the testosterone chain. Less GnRH means the pituitary gland releases less LH, so the testicles make less testosterone. Opioids can also raise prolactin, which may push testosterone down further.

Here's the chain in four steps:

  1. Your hypothalamus releases GnRH (gonadotropin-releasing hormone). Opioids slow this down.
  2. Your pituitary gland releases LH and FSH in response. LH (luteinizing hormone) tells the testicles to make testosterone. FSH (follicle-stimulating hormone) helps support sperm production. With opioid suppression, LH is often low or inappropriately normal, and FSH may also be affected.
  3. Your testicles make less testosterone because they're getting a weaker signal.
  4. Symptoms can appear — including low sex drive, sexual problems, low mood, reduced muscle mass, infertility, or bone loss.

How fast does it happen?

Faster than most people expect. Opioids can suppress the gonadal axis soon after they are given. With steady daily use, testosterone can remain low in some men, but the size and duration of the effect vary by opioid, dose, route, and person.

Does the dose matter?

Often, yes. In one study of 1,159 men, every extra 10 mg a day of hydrocodone raised the odds of low testosterone. In other studies, how the opioid works — long-acting versus short-acting — mattered even more than the dose.

Why buprenorphine is usually milder

Methadone, oxycodone, morphine, and fentanyl are full opioid-receptor agonists. Buprenorphine is a partial agonist with lower intrinsic activity at the mu-opioid receptor. The Endocrine Society notes that this pharmacology may help explain why buprenorphine tends to produce less gonadal-axis suppression than full agonists.


Opioid-Induced Hypogonadism Symptoms: What Does It Feel Like?

The most common signs are low sex drive, erection problems, fatigue, low mood, and loss of muscle or strength. Many of these overlap with chronic pain, depression, poor sleep, and the opioid itself. That's why symptoms alone can't diagnose opioid-induced hypogonadism.

Check the ones that sound like you. This isn't a test. It's a list to bring to your clinician.

  • Low sex drive
  • Trouble getting or keeping an erection
  • Fewer morning erections
  • Low energy that sleep doesn't fix
  • Low mood or irritability
  • Hot flashes or sweating
  • Losing muscle or strength
  • More belly fat
  • Trouble focusing

"Is it the opioids or is it me?"

It's one of the most common questions men on opioids ask. The honest answer is that it could be the opioid, something else, or both.

Chronic pain alone wears you down. So do depression, poor sleep, sleep apnea, weight gain, and other medicines like steroids. Alcohol plays a part too. That's why testing matters more than any checklist. For more on these overlaps, see fatigue and depression guidance.

⚠️ When fatigue may not be testosterone at all

The FDA warns that opioids can, rarely, cause adrenal insufficiency. That means your adrenal glands don't make enough cortisol, a hormone your body needs, especially under stress.

Watch for:

  • Nausea or vomiting
  • Loss of appetite
  • Fatigue or weakness
  • Dizziness
  • Low blood pressure

In a review of the research, low cortisol turned up in roughly 15% to 24% of people on opioids. That figure comes from only a handful of studies. Still, it matters. If you have these symptoms, get medical care promptly. Testosterone won't fix a cortisol problem. Ask your clinician whether a cortisol test makes sense.

What about your bones?

Low testosterone and long-term opioid use can both affect bone strength. The Endocrine Society's 2024 statement reviews growing evidence that opioids are linked to lower bone density and more fractures. If you've been on opioids for years, ask whether a bone density scan (called a DXA scan) makes sense for you.


Does Methadone Lower Testosterone?

Yes. Methadone is one of the most testosterone-suppressing opioids. In one study, about 65% of men on methadone treatment had testosterone below about 346 ng/dL, compared with 28% of men on buprenorphine. In a separate pain study, methadone carried about seven times the odds of low testosterone compared with hydrocodone.

A second study from Southeast Asia found the same pattern: 40.8% of men on methadone had testosterone below the normal range, versus 22.6% on buprenorphine. Different country, different lab, same direction.

If you're on methadone for opioid use disorder

Methadone treatment saves lives. Low testosterone is a known side effect of it. It's not a reason to question your treatment. And it's not something you should have to hide.

You shouldn't have to choose between keeping your recovery stable and taking your hormone symptoms seriously. You can do both.

Bringing up low sex drive or fatigue with your treatment program is a medical conversation, not drug-seeking. Your program can order labs or coordinate with your primary care clinician or an endocrinologist.

If you're on methadone for pain

The same data applies. Your prescriber may want to review your pain plan. But that's their call to make with you — not a change to make on your own.

Does a higher methadone dose mean lower testosterone?

Not always in a straight line. Some studies hint at a link between dose and testosterone. But the Hallinan study team pointed out that people break down methadone very differently. That can hide any clear dose pattern. So a lower dose isn't a guaranteed fix.

Should you stop methadone because your testosterone is low?

No — not on your own. For someone in opioid use disorder treatment, staying stable matters far more than any hormone number. Low testosterone has other options, which we cover below.


Does Buprenorphine (Suboxone) Lower Testosterone?

It can, but usually less than methadone. Men on buprenorphine treatment had lower testosterone than men not on opioids, but higher testosterone and fewer sexual side effects than men on methadone. Low testosterone on buprenorphine still has to be confirmed with proper testing, not assumed or ruled out.

Buprenorphine vs. methadone at a glance

Opioid-induced hypogonadism: testing, opioid evidence and treatment options table 3: Buprenorphine vs. methadone at a glance
Methadone Buprenorphine
Below about 346 ng/dL (Hallinan) 65% 28%
Below about 231 ng/dL (Hallinan) 39% 11%
Below the lab's normal range (Yee, 2018) 40.8% 22.6%
Sexual side effects More common Less common
How it works on the opioid receptor Full agonist Partial agonist
Can low testosterone still happen? Yes Yes

What "less suppressive" does NOT mean

You'll hear online that "Suboxone doesn't touch your T." That goes too far. Here's what the research does not say:

  • It doesn't say buprenorphine is hormone-neutral.
  • It doesn't promise your testosterone will be normal.
  • It doesn't say buprenorphine is the better choice for every person.
  • It doesn't say you should switch medicines to fix your testosterone.

What it does say: on average, men on buprenorphine have less testosterone suppression than men on methadone. If you have symptoms, you deserve the same testing as anyone else.

Suboxone vs. Sublocade vs. buprenorphine patches

Most studies looked at buprenorphine taken under the tongue. We didn't find strong testosterone data that compares Suboxone, Sublocade, and buprenorphine patches with each other. So we're not ranking them.


Other Opioids and Testosterone: Oxycodone, Fentanyl, Morphine, Hydrocodone, Tramadol

Many opioids studied in men can suppress testosterone, but the risk is not equal. In one large cohort, transdermal fentanyl, methadone, and oxycodone were associated with higher odds of androgen deficiency than hydrocodone. Separate studies also found higher odds with long-acting opioids than with short-acting opioids.

  • Fentanyl patch: The highest odds in the study of 1,159 men — about 26× versus hydrocodone. The range was very wide because few men used it. It's still a strong warning sign.
  • Oxycodone: About 3× the odds versus hydrocodone. Long-acting (extended-release) versions tend to suppress more.
  • Morphine: Commonly studied, and long-acting morphine falls in the higher-risk long-acting group.
  • Hydrocodone: The comparison group in that study. Risk still rose with dose.
  • Intrathecal (pump) opioids: Testosterone dropped fast and stayed low in a small study.
  • Tramadol and kratom: We didn't find strong human data to rank them. If you take either one daily and have symptoms, the testing steps below still apply.

What about a short course after surgery?

Short-term opioid exposure can temporarily suppress testosterone, so a result taken during a brief course may not reflect your usual level. If symptoms persist after the short course ends, or your clinician has another reason to suspect hypogonadism, ask when testing would be most useful.


How Is Opioid-Induced Hypogonadism Diagnosed?

Clinicians diagnose hypogonadism when symptoms or signs occur with unequivocally and consistently low testosterone, confirmed with repeat morning testing. If hypogonadism is confirmed, LH and FSH help distinguish primary from secondary disease; with opioid-related secondary hypogonadism, LH is often low or inappropriately normal. Tell the clinician when you last took your opioid because short-acting doses can transiently affect testosterone.

What the guidelines say

The Endocrine Society's 2018 guideline sets the standard. Diagnose hypogonadism only when a man has symptoms or signs and testosterone that is clearly and consistently low. Start with a fasting, early-morning total testosterone test from an accurate lab. Then repeat it to confirm.

The American Urological Association (AUA) agrees. It needs low total testosterone plus symptoms or signs. The AUA uses below 300 ng/dL as a reasonable cutoff. It also says to measure LH when testosterone is low.

Neither group lets one number make the diagnosis. For more, see Do You Need Two Low Testosterone Tests for TRT? and What Testosterone Level Qualifies for TRT?

Should men on long-term opioids get checked?

The Endocrine Society lists opioid use among the situations where checking testosterone makes sense. The 2020 meta-analysis authors went further. They suggested periodic checks of both testosterone and cortisol in people on long-term opioids — especially those with symptoms.

Why one test can fool you

Short-acting opioids can push testosterone down for a few hours after a dose. One researcher showed how this can lead to a wrong diagnosis if only one morning test is used. That's why two tests — with your dose time written down — matter so much on opioids.

The opioid lab-prep checklist

Screenshot this. Bring it to your appointment.

  1. Book a morning blood draw. The Endocrine Society recommends a fasting morning total testosterone measurement; follow your clinician's and lab's instructions.
  2. Plan on two tests, on different days.
  3. Take your opioid exactly as prescribed. Don't skip or delay a dose to "get a better number."
  4. Write down the time of your last dose. Tell the person ordering the test.
  5. If low testosterone is confirmed, ask about LH and FSH. These help show whether the problem is primary (testicular) or secondary (hypothalamic-pituitary).
  6. Ask whether prolactin should be checked. Opioids can raise it, and very high levels need their own workup. Very high prolactin can require its own workup.
  7. Mention any nausea, vomiting, dizziness, weakness, or low blood pressure. Ask about a cortisol test.
  8. If your testosterone comes back very low, ask about a pituitary check. The Endocrine Society suggests considering pituitary imaging in men with secondary hypogonadism and testosterone below 150 ng/dL, among other reasons.
  9. Ask whether free testosterone matters for you. If your total testosterone is borderline, or a protein called SHBG (sex hormone-binding globulin) is off, a properly measured free testosterone can help.
  10. If you might want kids, ask for a reproductive health evaluation before any testosterone. A clinician can decide whether semen analysis is appropriate.
  11. Bring a full medication list, including your methadone or buprenorphine dose and any steroids.

For more on arranging testosterone testing, see Where to Get a Testosterone Test.

Who should order the tests?

  • First labs: your primary care clinician or the clinician who prescribes your opioid.
  • Methadone or buprenorphine treatment: your treatment program may be able to order labs or coordinate care with primary care or a specialist.
  • Endocrinology: for very low testosterone, high prolactin, a possible pituitary or adrenal problem, or confusing results.
  • Urology or reproductive urology: if fertility matters to you.

Is Opioid-Induced Hypogonadism Reversible?

It can be. The Endocrine Society notes that reducing or stopping opioid exposure can allow the gonadal axis to recover, but the time course is variable and recovery is not guaranteed for every person. Any opioid change has to be planned with the clinician managing that treatment.

What recovery looks like

Because opioid-related hypogonadism is often secondary, hormone signaling can improve after opioid exposure is reduced or stopped. But another cause may also be present, and nobody has a dependable "you'll be back in X weeks" number. Be wary of any page that gives you one.

The practical approach: after a stable change, recheck your labs with your clinician rather than counting down to a fixed date.

Should you switch from methadone to buprenorphine to fix your testosterone?

This is the question men on methadone ask most. Here's our honest take.

Buprenorphine is linked to less testosterone suppression than methadone in several studies. But whether switching reliably brings testosterone back has not been established in good comparative trials.

Switching medicines for opioid use disorder can cause withdrawal during the transition and can destabilize treatment if it is not managed carefully. So this is a recovery decision, not a hormone fix. It belongs with your treatment team. If your testosterone is low and you're stable on methadone, the hormone problem can be evaluated without making a self-directed medication change.

Should you lower your pain medicine to raise your testosterone?

Only as a planned decision with your prescriber. The U.S. Department of Health and Human Services (HHS) warns against tapering opioids fast or stopping them suddenly, except when there's a life-threatening problem. Sudden changes can cause withdrawal, worse pain, and psychological distress.

Low testosterone is a fair reason to talk about your pain plan. That's where it starts and stops.

If you're struggling with opioid use, help is free and confidential. Call the SAMHSA National Helpline at 1-800-662-4357, 24/7. If you're in crisis, call or text 988.


How Is Opioid-Induced Hypogonadism Treated?

Treatment depends on whether hypogonadism is confirmed, why the opioid is being used, whether the opioid can safely change, fertility plans, and other health risks. Options can include rechecking after a clinician-planned opioid change, reviewing the pain or OUD treatment plan, testosterone therapy for appropriately selected men, or specialist-guided non-testosterone treatment when fertility is a priority.

Your options, side by side

Opioid-induced hypogonadism: testing, opioid evidence and treatment options table 4: Your options, side by side
Option When it's considered Who decides The catch
Wait and recheck Short-term use, or after a planned taper or stop Primary care or your prescriber Takes time, and there's no fixed timeline
Review the pain or treatment plan Long-term use where alternatives exist Pain prescriber or treatment program Never self-directed — pain control and recovery come first
Testosterone therapy Confirmed low testosterone plus symptoms, opioid continuing, no reasons to avoid it, no near-term plans for kids Primary care, endocrinology, urology, or a licensed telehealth clinician Lowers sperm production and needs ongoing monitoring
Non-testosterone options Fertility is a priority and a specialist thinks another approach fits Reproductive urology or endocrinology These are not TRT. Clomiphene use for male hypogonadism is off-label; hCG has specific FDA-approved male indications, but opioid-specific evidence is limited
Treat other problems Depression, sleep apnea, weight, other medicines Primary care or specialists May help symptoms whether or not testosterone changes

Does testosterone therapy work for opioid-induced low T?

Randomized evidence is limited. One well-known 14-week trial tested testosterone gel, and a separate 24-week randomized trial later tested testosterone undecanoate injections in opioid-treated men with hypogonadism. Researchers gave men ages 18 to 64 — all on opioids for chronic pain that wasn't from cancer, with testosterone below 350 ng/dL — either testosterone gel or a placebo for 14 weeks. Of the 84 men who started, 65 had follow-up data.

The men on testosterone saw improvements in:

  • Pain sensitivity on lab tests
  • Sex drive
  • Body composition (more lean mass, less fat)
  • Some quality-of-life measures

What it did not do:

  • It didn't reduce how much opioid medicine the men used.
  • It didn't meaningfully change how much pain they reported day to day.
  • Later analyses found no change in sleep quality or pain catastrophizing (the tendency to dwell on pain).

Later analyses of the 14-week trial found no meaningful change in several metabolic or inflammatory markers, and separate analyses found no improvement in sleep quality or pain catastrophizing. A later 24-week randomized trial found improved body composition but no significant improvement in pain perception or quality of life.

A larger trial called PATH is still recruiting. ClinicalTrials.gov lists an estimated primary completion date of September 2027, with no results posted as of this page's verification date.

Will testosterone help you need fewer opioids?

There's no evidence it does. The trial found no difference in opioid use. The lead researcher has said he wouldn't start testosterone just to treat pain. Testosterone treats confirmed low testosterone. It isn't a pain medicine.

What testosterone therapy doesn't fix

  • It doesn't explain why your testosterone is low.
  • It doesn't treat opioid use disorder.
  • It doesn't replace your pain plan.
  • It doesn't solve every cause of fatigue or sexual problems.
  • It doesn't guarantee you'll feel better.

FDA-approved vs. compounded testosterone

This difference matters, so let's be plain about it.

  • FDA-approved testosterone is available in several formulations, including injections, topical products, patches, buccal systems, nasal products, and oral testosterone products. FDA approval applies to the specific product and labeled indication.
  • Compounded testosterone is mixed by a pharmacy for an individual patient. It is not FDA-approved. The FDA doesn't review compounded drugs the same way.

Neither is automatically right for you. Just know which one you're getting. For more, see our oral testosterone guide.

Testosterone safety in this situation

Testosterone therapy needs monitoring. That includes blood counts (hematocrit — the share of your blood made up of red cells), PSA (prostate-specific antigen, a blood test used in prostate risk assessment) when appropriate, and blood pressure. In 2025, the FDA updated testosterone labels to add a blood pressure warning.

The Endocrine Society advises against starting testosterone in men with untreated severe sleep apnea, elevated hematocrit, and several other conditions. See Who Should Not Take TRT? and TRT Side Effects.

Also make sure every clinician knows about every medicine you take — your opioid prescriber should know about testosterone, and your testosterone prescriber should know about your opioid.

Discuss treatment decisions with your clinician. Use the options table and appointment questions on this page with your opioid prescriber or treatment program. Find My TRT Path does not choose whether to taper, switch, treat, or wait. Once your clinician has completed the evaluation and addressed specialist concerns, the tool can help you compare online TRT options. Explore online TRT options → Free. It won't diagnose you or promise a prescription.


Opioids, Testosterone, and Fertility: What to Know Before Any Treatment

If you want children now or soon, see a reproductive urologist before starting testosterone. Testosterone therapy can lower sperm production, and the Endocrine Society recommends against it for men planning fertility in the near term. Opioids themselves may also affect sperm, though the human research on that is small and older.

Here's the part that surprises a lot of men. Adding testosterone from outside the body tells your brain you have plenty. So your brain turns the signal down even more. That can drop sperm production further.

The AUA says men with low testosterone who are interested in fertility should have a reproductive health evaluation before treatment.

Some non-testosterone options may be considered by fertility-aware specialists. These are not TRT. Clomiphene is FDA-approved for ovulatory dysfunction in women and is used off-label for male hypogonadism. hCG has FDA-approved indications in selected males with hypogonadotropic hypogonadism, but whether it fits a man with opioid-associated hypogonadism is an individual specialist decision. Opioid-specific evidence is limited.

Learn more: hCG vs. Clomid · hCG With TRT · hCG Online for Men


Can You Get TRT Online While Taking Opioids, Methadone, or Suboxone?

Sometimes, but it often should not be the first stop while the cause is still being worked out. Primary care, endocrinology, urology, reproductive urology, or the clinician managing the opioid may need to coordinate the evaluation. Online TRT may fit later when hypogonadism is confirmed, major causes and fertility issues have been addressed, and the program's clinician can safely manage the case.

Online care can be the right step — once the groundwork is done

Online care may be reasonable to discuss if:

  • You've had two low morning testosterone tests
  • LH and FSH were checked
  • Your opioid prescriber or treatment program knows you're looking into testosterone
  • You don't plan to have kids in the near term
  • You have none of the warning signs listed below

Not ready for this step if:

  • You've only had one test, or none
  • You're in the middle of a taper
  • Fertility is a near-term goal → see the fertility section above
  • You have nausea, vomiting, dizziness, weakness, or low blood pressure → get checked for adrenal problems first
  • Your testosterone is extremely low and nobody has checked your pituitary
  • You want FDA-approved testosterone covered by insurance → start with primary care, endocrinology, or urology

What the law says right now

Testosterone is a Schedule III controlled substance. That's a federal category for drugs with accepted medical use and some misuse risk. It always requires a valid prescription.

DEA and HHS have extended the current federal telemedicine flexibilities through December 31, 2026. Under those flexibilities, a DEA-registered practitioner may prescribe Schedule II–V controlled substances through an audio-video telemedicine encounter without a prior in-person medical evaluation when all other federal and state requirements are met. Testosterone is Schedule III. State law and a program's own policy can still require additional steps.

What to verify before using an online TRT program

For this topic, the online clinic should come after the diagnostic work, not before it. Before you pay, check whether the program:

  • Requires a proper repeat testosterone measurement rather than treating one low result as the diagnosis
  • Reviews LH and FSH when secondary hypogonadism needs to be distinguished from primary testicular disease
  • Has a clear plan for prolactin, pituitary, adrenal, or fertility concerns when the history calls for it
  • Will coordinate with the clinician managing your opioid, methadone, or buprenorphine
  • Tells you whether the testosterone product is FDA-approved or compounded
  • Explains laboratory monitoring, clinician follow-up, pharmacy fulfillment, total cost, cancellation, and medical-record access before you commit

TRT Provider Guide does not have public evidence that a specific online TRT program is the best first choice for opioid-induced hypogonadism. The right starting point may be primary care, endocrinology, urology, reproductive urology, a pain clinician, or your opioid-treatment program depending on what still needs to be sorted out.

Already have confirmed low testosterone but not sure whether online care belongs in your plan? Review the questions above with your clinician and opioid prescriber or treatment program. When they agree online TRT is an appropriate option to explore after evaluation, Find My TRT Path can help you compare online programs. Explore online TRT options → Free. Educational, not a diagnosis or a promise of treatment.


Does Insurance Cover Testosterone for Opioid-Induced Low T?

It may. Coverage for FDA-approved testosterone varies by insurer and plan, and some plans require prior authorization or specific laboratory documentation. Check your plan's current criteria before paying cash or assuming a prescription will be covered.

A diagnosis of opioid-induced hypogonadism does not guarantee coverage. Your clinician documents the diagnosis and the testing that supports it, then the plan applies its own rules. Compounded testosterone is not FDA-approved and generally follows a different cash-pay path rather than standard pharmacy-benefit coverage.

Plan-specific guides:


Questions to Ask Before Starting Testosterone While Taking Opioids

The best questions check that the diagnosis is solid, that your opioid plan has been considered, that fertility is covered, and that monitoring is in place. They also make sure every clinician involved knows about every medicine you take.

  1. Was my low testosterone confirmed with two morning tests?
  2. Do my LH and FSH point to a brain-signal (secondary) cause?
  3. Could anything else be causing this — sleep apnea, depression, weight, or other medicines?
  4. Should my cortisol or prolactin be checked?
  5. Can my opioid plan safely change, and who decides that?
  6. Does my opioid prescriber or treatment program know I'm considering testosterone?
  7. If I might want kids, should I see a reproductive urologist first?
  8. Is the testosterone you'd prescribe FDA-approved or compounded?
  9. What would testosterone realistically improve for me — and what won't it change?
  10. How will you monitor my hematocrit, blood pressure, and testosterone levels?
  11. What happens if I don't feel better?

Can Women Get Opioid-Induced Hypogonadism?

Yes. In women, opioids can lower estrogen and other sex hormones. That can show up as irregular or missed periods, low sex drive, or hot flashes. Women need a different approach from men's TRT, so a gynecologist or endocrinologist is the right place to start.

One small study of people taking oral opioids for chronic pain found hypogonadism in 75% of men but only 21% of premenopausal women. A larger meta-analysis found opioids lowered testosterone in men but not in women.

No testosterone product is currently FDA-approved in the U.S. specifically for treatment of women. The TRT evaluation and treatment sections on this page are written for adult men.


How We Built This Page

Every number on this page comes from peer-reviewed studies, FDA safety communications, federal health guidance, clinical guidelines, or current federal rulemaking. We combined them into opioid-by-opioid tables you won't find together anywhere else.

Here's what we did:

  • Pulled the research. Meta-analyses, cohort studies, and the main randomized trial on testosterone in men taking opioids.
  • Checked the rules. The FDA's opioid and testosterone safety actions, the DEA's telemedicine rule, and HHS guidance on tapering.
  • Read the guidelines. The Endocrine Society's 2018 testosterone guideline and 2024 opioid statement, and the AUA's testosterone deficiency guideline.
  • Kept our opinions labeled. "Get confirmed before you go online" and "don't switch your treatment medicine to fix your testosterone" are our editorial conclusions. They're based on the facts above.

The limits: Most opioid-testosterone studies are observational, many are small, and some are older. Randomized testosterone trials in this population are still limited and have not shown consistent improvement in pain or quality of life. We'll update this page as new research and rules come out.

Our full process is in How We Review TRT Providers.


Frequently Asked Questions

Do opioids lower testosterone?

Yes. With regular use, most opioids can lower testosterone by turning down the brain signals (GnRH and LH) that tell the testicles to make it. In pooled studies, about 63% of men on long-term opioids had hypogonadism. Methadone and long-acting opioids tend to have the biggest effect.

Is opioid-induced hypogonadism permanent?

Usually not. Because opioids suppress the signal rather than damage the testicles, testosterone often recovers after opioids are reduced or stopped. Recovery time varies, and some men need treatment. Any change to your opioid should be planned with your prescriber.

How long does it take for testosterone to recover after stopping opioids?

There's no reliable universal timeline. It depends on the opioid, the dose, and how long you took it. The safest approach is to recheck your labs with your clinician after a stable change, instead of counting on a fixed date.

Does Suboxone lower testosterone?

It can, but usually less than methadone. In one study, 28% of men on buprenorphine had testosterone below about 346 ng/dL, compared with 65% of men on methadone. If you have symptoms on Suboxone, get tested the same way anyone else would.

Does methadone lower testosterone?

Yes. Methadone is among the most suppressing opioids. Studies of men in methadone treatment have found low testosterone in roughly 40% to 65%, depending on the study and the cutoff used. Don't change your methadone on your own because of it.

Can I take TRT while on Suboxone or methadone?

Possibly, when low testosterone is confirmed with proper testing and your treatment team knows. Testosterone doesn't replace or change your opioid use disorder treatment. Your treatment program and your testosterone prescriber should both know about each other.

Will TRT help my chronic pain?

Not in the way most people hope. In a 14-week trial, testosterone gel improved pain sensitivity on lab tests, but it didn't meaningfully change day-to-day pain or reduce opioid use. Testosterone treats confirmed low testosterone, not pain.

Should I lower my opioid dose to raise my testosterone?

Only as a planned decision with your prescriber. HHS warns against fast tapers or sudden stops because of withdrawal, worse pain, and other risks. Low testosterone is a fair reason to discuss your plan, not to change it yourself.

What tests do I need for opioid-induced hypogonadism?

Two early-morning total testosterone tests on different days, plus LH and FSH. Your clinician may also check prolactin, and cortisol if you have symptoms like nausea or dizziness. Write down when you took your last opioid dose and share it.

What is OPIAD?

OPIAD stands for opioid-induced androgen deficiency. It's another name for opioid-induced hypogonadism in men: low testosterone caused by opioid use.

Can opioids cause erectile dysfunction?

Yes. Erection problems are common in men on long-term opioids, and men on methadone report them more often than men on buprenorphine. Low testosterone is one cause, but depression, other medicines, and blood vessel health can play a part too.

Does tramadol lower testosterone?

Tramadol is an opioid, so it may. We didn't find strong enough human data to say how much it affects testosterone compared with other opioids. If you take it daily and have symptoms, the same testing steps apply.

Can women get opioid-induced hypogonadism?

Yes. Opioids can lower sex hormones in women, which may cause irregular periods, low sex drive, or hot flashes. Women should see a gynecologist or endocrinologist. No testosterone product is FDA-approved for women in the U.S.

Can I get treated for opioid-induced low T online?

Sometimes. Online programs can make sense after low testosterone is confirmed, your opioid prescriber knows, and you have no near-term fertility plans. Check the verified details above, and tell the program about every medicine you take.


Ready to compare online TRT programs after your clinician has evaluated the cause and addressed opioid coordination and specialist concerns? Use our free Find My TRT Path tool.


Sources

  1. Karavitaki N, et al. Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement. Endocrine Reviews. 2024.
  2. de Vries F, et al. Opioids and Their Endocrine Effects: A Systematic Review and Meta-analysis. Journal of Clinical Endocrinology & Metabolism. 2020.
  3. Bawor M, et al. Testosterone suppression in opioid users: a systematic review and meta-analysis. Drug and Alcohol Dependence. 2015.
  4. Rubinstein AL, et al. Hypogonadism in men with chronic pain linked to the use of long-acting rather than short-acting opioids. Clinical Journal of Pain. 2013.
  5. Rubinstein AL, Carpenter DM. Elucidating risk factors for androgen deficiency associated with daily opioid use. American Journal of Medicine. 2014.
  6. Rubinstein AL, Carpenter DM. Association Between Commonly Prescribed Opioids and Androgen Deficiency in Men. Pain Medicine. 2017.
  7. Hallinan R, et al. Hypogonadism in men receiving methadone and buprenorphine maintenance treatment. International Journal of Andrology. 2009.
  8. Yee A, et al. Plasma Testosterone and Sexual Function in Southeast Asian Men Receiving Methadone and Buprenorphine Maintenance Treatment. Journal of Sexual Medicine. 2018.
  9. Daniell HW. Transient low testosterone levels after oral hydrocodone may contribute to misdiagnosis of hypogonadism. Journal of Opioid Management. 2016.
  10. Basaria S, et al. Effects of testosterone replacement in men with opioid-induced androgen deficiency: a randomized controlled trial. Pain. 2015.
  11. Glintborg D, et al. Testosterone replacement therapy of opioid-induced male hypogonadism improved body composition but not pain perception: a randomized placebo-controlled trial. European Journal of Endocrinology. 2020.
  12. Huang G, et al. Effects of Testosterone Replacement on Pain Catastrophizing and Sleep Quality in Men with Opioid-Induced Androgen Deficiency. Pain Medicine. 2017.
  13. Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. JCEM. 2018.
  14. Endocrine Society. Statement on Testosterone Replacement Therapy. July 16, 2026.
  15. American Urological Association. Evaluation and Management of Testosterone Deficiency. 2018; validity confirmed 2024.
  16. U.S. Food and Drug Administration. FDA warns about several safety issues with opioid pain medicines; requires label changes. 2016.
  17. U.S. Food and Drug Administration. Testosterone Information. Accessed October 2026.
  18. U.S. Food and Drug Administration. FDA issues class-wide labeling changes for testosterone products. 2025.
  19. U.S. Drug Enforcement Administration. Drug Scheduling. Accessed October 2026.
  20. U.S. Drug Enforcement Administration. DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care. December 31, 2025.
  21. U.S. Department of Health and Human Services. HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics. 2019.
  22. SAMHSA. What is Methadone?. Accessed October 2026.
  23. SAMHSA. Crisis Help: Suicide, Mental Health, Drug, and Alcohol Issues. Accessed October 2026.
  24. ClinicalTrials.gov. Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism (PATH), NCT04798469. Record updated 2026.
  25. Fraser LA, et al. Oral opioids for chronic non-cancer pain: higher prevalence of hypogonadism in men than in women. Experimental and Clinical Endocrinology & Diabetes. 2009.
  26. U.S. Food and Drug Administration. Public Meeting: Testosterone Use in Menopausal Women. September 17, 2026.

Not sure which TRT route fits you?

Find My TRT Path